339 related articles for article (PubMed ID: 36004816)
21. C-Type natriuretic peptide/guanylate cyclase B system in rat osteogenic ROB-C26 cells and its down-regulation by dexamethazone.
Suda M; Komatsu Y; Tanaka K; Yasoda A; Sakuma Y; Tamura N; Ogawa Y; Nakao K
Calcif Tissue Int; 1999 Dec; 65(6):472-8. PubMed ID: 10594167
[TBL] [Abstract][Full Text] [Related]
22. Coexistence of C-type natriuretic peptide and atrial natriuretic peptide systems in the bovine cornea.
Kim SZ; Kim HS; Lee KS; Lee SJ; Seul KH; Koh GY; Cho KW; Kim SH
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2671-7. PubMed ID: 10937581
[TBL] [Abstract][Full Text] [Related]
23. Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.
Potter LR
Pharmacol Ther; 2011 Apr; 130(1):71-82. PubMed ID: 21185863
[TBL] [Abstract][Full Text] [Related]
24. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice.
Kuhn M
Peptides; 2005 Jun; 26(6):1078-85. PubMed ID: 15911075
[TBL] [Abstract][Full Text] [Related]
25. Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure.
Vassalle C; Andreassi MG; Prontera C; Fontana M; Zyw L; Passino C; Emdin M
Clin Chem; 2007 Nov; 53(11):1886-90. PubMed ID: 17890443
[TBL] [Abstract][Full Text] [Related]
26. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases.
Tremblay J; Desjardins R; Hum D; Gutkowska J; Hamet P
Mol Cell Biochem; 2002 Jan; 230(1-2):31-47. PubMed ID: 11952095
[TBL] [Abstract][Full Text] [Related]
27. Electrophysiological effects of natriuretic peptides in the heart are mediated by multiple receptor subtypes.
Moghtadaei M; Polina I; Rose RA
Prog Biophys Mol Biol; 2016 Jan; 120(1-3):37-49. PubMed ID: 26701223
[TBL] [Abstract][Full Text] [Related]
28. Local renal and vascular natriuretic peptide system in obstructive uropathic rats.
Kim SW; Li Y; Kim S; Oh YW; Lee JU
Urol Res; 2002 May; 30(2):97-101. PubMed ID: 12086022
[TBL] [Abstract][Full Text] [Related]
29. Differential expression and synthesis of natriuretic peptides determines natriuretic peptide receptor expression in primary cultures of human proximal tubular cells.
Mistry SK; Hawksworth GM; Struthers AD; McLay JS
J Hypertens; 2001 Feb; 19(2):255-62. PubMed ID: 11212968
[TBL] [Abstract][Full Text] [Related]
30. Roles of guanylyl cyclase--a signaling in the cardiovascular system.
Saito Y; Kishimoto I; Nakao K
Can J Physiol Pharmacol; 2011 Aug; 89(8):551-6. PubMed ID: 21671770
[TBL] [Abstract][Full Text] [Related]
31. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
32. Autocrine and paracrine actions of natriuretic peptides in the heart.
D'Souza SP; Davis M; Baxter GF
Pharmacol Ther; 2004 Feb; 101(2):113-29. PubMed ID: 14761702
[TBL] [Abstract][Full Text] [Related]
33. Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators.
Sangaralingham SJ; Whig K; Peddibhotla S; Kirby RJ; Sessions HE; Maloney PR; Hershberger PM; Mose-Yates H; Hood BL; Vasile S; Pan S; Zheng Y; Malany S; Burnett JC
Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34930837
[TBL] [Abstract][Full Text] [Related]
34. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Potter LR; Yoder AR; Flora DR; Antos LK; Dickey DM
Handb Exp Pharmacol; 2009; (191):341-66. PubMed ID: 19089336
[TBL] [Abstract][Full Text] [Related]
35. C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.
Savoie P; de Champlain J; Anand-Srivastava MB
FEBS Lett; 1995 Aug; 370(1-2):6-10. PubMed ID: 7649305
[TBL] [Abstract][Full Text] [Related]
36. Expression of C-type natriuretic peptide in the bovine pineal gland.
Middendorff R; Maronde E; Paust HJ; Muller D; Davidoff M; Olcese J
J Neurochem; 1996 Aug; 67(2):517-24. PubMed ID: 8764575
[TBL] [Abstract][Full Text] [Related]
37. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
[TBL] [Abstract][Full Text] [Related]
38. Hormonal regulation of natriuretic peptide system during induced ovarian follicular development in the rat.
Gutkowska J; Jankowski M; Sairam MR; Fujio N; Reis AM; Mukaddam-Daher S; Tremblay J
Biol Reprod; 1999 Jul; 61(1):162-70. PubMed ID: 10377045
[TBL] [Abstract][Full Text] [Related]
39. Role of Cardiac Natriuretic Peptides in Heart Structure and Function.
Sarzani R; Allevi M; Di Pentima C; Schiavi P; Spannella F; Giulietti F
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430893
[TBL] [Abstract][Full Text] [Related]
40. Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide.
Ichiki T; Dzhoyashvili N; Burnett JC
Int J Cardiol; 2019 Apr; 281():166-171. PubMed ID: 29941213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
